Quadramet cancer data

In a U.S. trial in 14 patients given 30 mCi/kg Quadramet followed by over 30 minutes 200 mg/m 2 gemcitabine and stem cell or bone marrow support, clinical responses were seen at the 6-8 week follow-up...